These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 32716955)
1. Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis. Kim MR; Kim AS; Choi HI; Jung JH; Park JY; Ko HJ PLoS One; 2020; 15(7):e0236445. PubMed ID: 32716955 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection. Gu L; Wang M; Cui X; Mo J; Yuan L; Mao F; Zhang K; Ng DM; Chen P; Wang D BMC Surg; 2020 Oct; 20(1):219. PubMed ID: 33008382 [TBL] [Abstract][Full Text] [Related]
3. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma. Li Y; Liu X; Zhang J; Yao W Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589 [TBL] [Abstract][Full Text] [Related]
4. Impact of systemic inflammation on gastric cancer outcomes. Liu X; Chen S; Liu J; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X PLoS One; 2017; 12(3):e0174085. PubMed ID: 28358923 [TBL] [Abstract][Full Text] [Related]
5. Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis. Jiang Y; Xu D; Song H; Qiu B; Tian D; Li Z; Ji Y; Wang J BMJ Open; 2021 Sep; 11(9):e048324. PubMed ID: 34593492 [TBL] [Abstract][Full Text] [Related]
6. Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis. Song X; Zhang H; Yin F; Guo P; Yang X; Liu J; Han Y; Ren Z Mediators Inflamm; 2021; 2021():3456629. PubMed ID: 34720749 [TBL] [Abstract][Full Text] [Related]
7. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis. Woo HD; Kim K; Kim J Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. Dutta S; Crumley AB; Fullarton GM; Horgan PG; McMillan DC Am J Surg; 2012 Sep; 204(3):294-9. PubMed ID: 22444831 [TBL] [Abstract][Full Text] [Related]
9. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis. Nie D; Zhang L; Wang C; Guo Q; Mao X Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927 [TBL] [Abstract][Full Text] [Related]
10. The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer. Knight K; Choong JX; McKee RF; Anderson JH; Horgan PG; McMillan DC; McDonald A; Roxburgh CS Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e22-e30. PubMed ID: 32709540 [TBL] [Abstract][Full Text] [Related]
11. Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer. Ghanim B; Schweiger T; Jedamzik J; Glueck O; Glogner C; Lang G; Klepetko W; Hoetzenecker K Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):616-23. PubMed ID: 26242317 [TBL] [Abstract][Full Text] [Related]
12. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. Song A; Eo W; Lee S World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer. Chen J; Hong D; Zhai Y; Shen P World J Surg Oncol; 2015 Mar; 13():122. PubMed ID: 25889889 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566 [TBL] [Abstract][Full Text] [Related]
15. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Guthrie GJ; Roxburgh CS; Farhan-Alanie OM; Horgan PG; McMillan DC Br J Cancer; 2013 Jul; 109(1):24-8. PubMed ID: 23799846 [TBL] [Abstract][Full Text] [Related]
17. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer. Powell AGMT; Parkinson D; Patel N; Chan D; Christian A; Lewis WG J Gastrointest Surg; 2018 Apr; 22(4):595-605. PubMed ID: 29234999 [TBL] [Abstract][Full Text] [Related]
20. The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study. Tan CS; Read JA; Phan VH; Beale PJ; Peat JK; Clarke SJ Support Care Cancer; 2015 Feb; 23(2):385-91. PubMed ID: 25112562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]